| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000040775 |
| Receipt No. | R000046543 |
| Scientific Title | Effectiveness of acupuncture therapy for the prevention of emergence agitation in children: A meta-analysis with trial sequential analysis |
| Date of disclosure of the study information | 2020/07/01 |
| Last modified on | 2021/06/16 (Ver. 2) |
| Basic information | ||
| Public title | Effectiveness of acupuncture therapy for the prevention of emergence agitation in children: A meta-analysis with trial sequential analysis | |
| Acronym | Effectiveness of acupuncture therapy for the prevention of emergence agitation in children: A meta-analysis with trial sequential analysis | |
| Scientific Title | Effectiveness of acupuncture therapy for the prevention of emergence agitation in children: A meta-analysis with trial sequential analysis | |
| Scientific Title:Acronym | Effectiveness of acupuncture therapy for the prevention of emergence agitation in children: A meta-analysis with trial sequential analysis | |
| Region |
|
|
| Condition | ||
| Condition | Emergence agitation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The primarily purpose of this meta-analysis is to assess the incidence of emergence agitation evaluated using a specific assessment tool compared with no treatment, placebo/sham, or standard care in children. |
| Basic objectives2 | Others |
| Basic objectives -Others | N/A |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary outcome is the incidence of emergence agitation evaluated using a specific assessment tool. We followed the definitions of the incidence of emergency agitation to the criteria established in each study. When emergence agitation was classified according to severity or points, we extract the data from the severe category. When emergence agitation was evaluated at several time points, we extract the data evaluated immediately after emergence (e.g. data evaluated on the PACU or in the recovery room) in order to extract the data that represented acute emergence agitation. |
| Key secondary outcomes | The secondary outcomes are the absolute value of the emergence agitation score evaluated using a specific assessment tool score, and the pain score evaluated using a specific assessment tool score. Incidence of adverse events such as nausea and vomiting, delayed awakening (Time to extubation, PACU stay duration) are also analyzed. |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Children undergoing general anesthesia and being expected to be extubated in the operating room. | |||
| Key exclusion criteria | Non-children (aged more than 18).
Children undergoing cardiac surgery with cardiopulmonary bypass or not expected to be extubated at the end of surgery. |
|||
| Target sample size | 0 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University Graduate School of Data Science | ||||||
| Division name | Department of Health Data Science | ||||||
| Zip code | 236-0027 | ||||||
| Address | 22-2 Seto Kanazawa-ku, Yokohama-shi, Kanagawa-ken, Japan | ||||||
| TEL | 045-787-2311 | ||||||
| w205659g@yokohama-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University Graduate School of Data Science | ||||||
| Division name | Department of Health Data Science | ||||||
| Zip code | 236-0027 | ||||||
| Address | 22-2 Seto Kanazawa-ku, Yokohama-shi, Kanagawa-ken, Japan | ||||||
| TEL | 045-787-2311 | ||||||
| Homepage URL | |||||||
| w205659g@yokohama-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Yokohama City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yokohama City University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Yokohama City University Graduate School of Data Science |
| Address | 22-2 Seto Kanazawa-ku, Yokohama-shi, Kanagawa-ken, Japan |
| Tel | 045-787-2311 |
| w205659g@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | The study protocol is attached in this pre-registration or can be seen at
http://www-user.yokohama-cu.ac.jp/~masuika/protocol/ <Searches> We will search the following electronic bibliographic database: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science. We will also search for trial registration sites such as ClinicalTrials.gov and University Medical Information Network Clinical Trial Registry. <Types of study to be included> We will include randomized controlled trials (RCTs) that evaluated the effect of acupuncture therapy for the prevention of emergence agitation compared with a placebo, no medication, standard care in children undergoing general anesthesia. <Risk of bias assessment> We assess the risk of bias using RoB2 tool for randomized, controlled trials. Trials with 1 or more risk of bias classified as some concerns or high are trials with a high risk of bias. We grade the quality of evidence of the main outcomes using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach with GRADEpro software. <Strategy for data synthesis and analysis> We will compare the incidence of the emergence agitation with risk ratio. We will summarize the risk ration with 95% confidence interval. We will use a random effect model to combine the result. Heterogeneity is quantified with I2 statistic. We plan to conduct subgroup analyses according to the following predefined factors when the I2 statistic exceeded 50%: (1) method of acupuncture therapy, (2) selection of points (unilateral or bilateral) (3) type of surgery. Sensitivity analysis is performed for primary outcomes according to the risk of bias (low vs high or unclear). For the primary outcome, Trial Sequential Analysis (TSA) is performed to correct for random error and repetitive testing of accumulating and sparse data. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046543 |